Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: A 15-year prospective study

Journal of Clinical Gastroenterology

Volumn 47, Issue 6, 2013, Pages 538-544

  Han, Kwang Hyub ^a,b,c   Kim, Do Young ^a,b,c   Park, Jun Yong ^a,b,c   Ahn, Sang Hoon ^a,b,c   Kim, Jieun ^a   Kim, Seung Up ^a,b   Kim, Ja Kyung ^a,b   Lee, Kwan Sik ^a,b,c   Chon, Chae Yoon ^a,c  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Centre   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Hepatocellular carcinoma; Screening; Surveillance; Survival

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84879884075     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182755c13     Document Type: Article

References (33)

1. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992;15: 948-963.
2. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22, 700 men in Taiwan. Lancet. 1981;2: 1129-1133.
3. Stevens CE, Beasley RP, Tsui J, et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292: 771-774.
4. Han KH, Kim JK. Liver cancer in Korea. Hepatol Res. 2007;37(suppl 2):S106-S109.
5. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcomes, and survival. Cancer. 1996;77: 2217-2222.
6. Calvet X, Bruix J, Gines P, et al. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology. 1990;12: 753-760.
7. Mor E, Kaspa RT, Sheiner P, et al. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med. 1998;129: 643-653.
8. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130: 417-422.
9. Sherman M. Surveillance for hepatocellular carcinoma and early diagnosis. Clin Liver Dis. 2007;11: 817-837.
10. Han K-H, Jeong JI, Ahn SH, et al. The efficacy of the ultrasonographic screening test for early detection of hepatocellular carcinoma and risk factors of HCC in Korea. Progress in Hepatocellular Carcinoma Treatment. Tokyo: Springer; 2000: 1-9.
11. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL Conference. J Hepatol. 2001;35: 421-430.
12. Trevisani F, Caraceni P, Bernardi M, et al. Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer. 1993;72: 1557-1563.
13. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 2nd English ed. Tokyo: Kanehara; 2003.
14. Bismuth H, Chiche L, Adam R, et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993;218: 145-151.
15. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334: 693-699.
16. Schwartz MA. Biomathematical approach to clinical tumor growth. Cancer. 1961;39: 1204-1294.
17. Trevisani F, De NS, Rapaccini G, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol. 2002;97: 734-744.
18. Yuen MF, Cheng CC, Lauder IJ, et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology. 2000;31: 330-335.
19. Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001;48: 251-259.
20. Sangiovanni A, Del Ninno E, Fasani P, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology. 2004;126: 1005-1014.
21. Stravitz RT, Heuman DM, Chand N, et al. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am J Med. 2008;121: 119-126.
22. Tong MJ, Sun HE, Hsien C, et al. Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic. Dig Dis Sci. 2010;55: 826-835.
23. Wong GL, Wong VW, Tan GM, et al. Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int. 2008;28: 79-87.
24. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991;325: 675-680.
25. Sheu JC, Sung JL, Chen DS, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology. 1985;89: 259-266.
26. Santi V, Trevisani F, Gramenzi A, et al. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J Hepatol. 2010;53: 291-297.
27. Santagostino E, Colombo M, Rivi M, et al. A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus. Blood. 2003; 102: 78-82.
28. Kojiro M, Shimamatsu K. Comparison of pathology of hepatitis B- and hepatitis C-related hepatocellular carcinoma. Viral Hepat Rev. 1995;5: 89-99.
29. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6: 674-687.
30. Kim Do Y, Kim SU, Ahn SH, et al. Usefulness of Fibroscan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci. 2009;54: 1758-1763.
31. Bruix J, ShermanM, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42: 1208-1236.
32. Fujita M, Kuroda C, Kumatani T, et al. Comparison between conventional and spiral CT in patients with hypervascular hepatocellular carcinoma. Eur J Radiol. 1994;18: 134-136.
33. Trinchet J, Chaffaut C, Bourcier V, et al. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3-months and 6-months periodicities. Hepatology. 2011;54: 1987-1997. and Welfare